4
Changes in Ownership
AIM ImmunoTech Inc. Filed Acc 0001583701-19-000002
Chief Science/Medical Officer acquired 50,010 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| STRAYER DAVID R Chief Science/Medical Officer | 2019-03-04 | Option exercise | +10 | 10 | D | ||
| STRAYER DAVID R Chief Science/Medical Officer | 2019-03-04 | Option exercise | +50,000 | 50,000 | D | ||
| Derivatives | |||||||
| STRAYER DAVID R Chief Science/Medical Officer | 2019-03-04 | Option exercise · Subr Rights(to buy) | +10 | $1,000.00 | $10,000 | 0 | D |
Loading xslF345X03/primary_doc.xml…